Enveric Biosciences, Inc. (ENVB) vs Traws Pharma, Inc. (TRAW)

Enveric Biosciences, Inc. and Traws Pharma, Inc. are both Biotechnology companies. Enveric Biosciences, Inc. and Traws Pharma, Inc. are of similar size ($7.3M and $6.9M). Traws Pharma, Inc. grew revenue faster over the last twelve months: 1,159.3% against −13.9%. Across the 12 metrics below, Enveric Biosciences, Inc. leads on 6 and Traws Pharma, Inc. on 6.

Valuation

Metric ENVB TRAW Biotechnology median
P/E n/m n/m 7.88
P/S 0.17 3.12 11.47
P/B 0.74 5.25 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.25 n/m 0.74
EV/Sales (0.06) 1.36 10.73
Earnings yield (442.99%) (314.29%) (28.84%)
Free cash flow yield (178.32%) (189.82%) (23.03%)

Profitability

Metric ENVB TRAW Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (235.48%) (319.42%) (57.72%)
Return on assets (193.53%) (117.35%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ENVB TRAW Biotechnology median
Revenue growth (TTM) (13.93%) 1,159.29% 5.64%
EPS growth (last fiscal year) 84.14% 100.76% —
Revenue growth, 5-year CAGR — 64.59% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ENVB TRAW Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 10.21 0.93 4.73
Net debt to EBITDA 0.55 0.21 0.96

Dividend

Metric ENVB TRAW Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ENVB TRAW Biotechnology median
Market cap 6.92m 7.26m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack